Obesity Surgery

, Volume 27, Issue 11, pp 3004–3005 | Cite as

Letter in Reply to Arno et al. “Pharmacokinetics in Morbid Obesity: Influence of Two Bariatric Surgery Techniques on Paracetamol and Caffeine Metabolism”

  • Victor Ferreira
  • Josh J. Wang
  • Eric Villeneuve
  • Sophie Gosselin
Letter to the Editor
  • 168 Downloads

References

  1. 1.
    Arno AG, Farré M, Rodríguez-Morató J, et al. Pharmacokinetics in morbid obesity: influence of two bariatric surgery techniques on paracetamol and caffeine metabolism. Obes Surg. Springer US. 40(6):1–8.Google Scholar
  2. 2.
    Dobrinas M, Cornuz J, Oneda B, et al. Impact of smoking, smoking cessation, and genetic polymorphisms on CYP1A2 activity and inducibility. Clin Pharmacol Ther. 2011;90(1):117–25.CrossRefPubMedGoogle Scholar
  3. 3.
    Faber MS, Fuhr U. Time response of cytochrome P450 1A2 activity on cessation of heavy smoking. Clin Pharmacol Ther. 2004;76(2):178–84.CrossRefPubMedGoogle Scholar
  4. 4.
    Faber MS, Jetter A, Fuhr U. Assessment of CYP1A2 activity in clinical practice: why, how, and when? Basic Clin Pharmacol Toxicol. 2005;97(3):125–34.CrossRefPubMedGoogle Scholar
  5. 5.
    Vistisen K, Poulsen HE, Loft S. Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine. Carcinogenesis. 1992;13(9):1561–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  1. 1.Department of PharmacyMcGill University Health CentreMontrealCanada
  2. 2.McGill FRCP Emergency Medicine ProgramMontrealCanada
  3. 3.Department of Emergency MedicineMcGill University Health CentreMontrealCanada

Personalised recommendations